337 related articles for article (PubMed ID: 24753979)
1. Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy.
Knight JC; Cornelissen B
Am J Nucl Med Mol Imaging; 2014; 4(2):96-113. PubMed ID: 24753979
[TBL] [Abstract][Full Text] [Related]
2. Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept.
Rondon A; Schmitt S; Briat A; Ty N; Maigne L; Quintana M; Membreno R; Zeglis BM; Navarro-Teulon I; Pouget JP; Chezal JM; Miot-Noirault E; Moreau E; Degoul F
Theranostics; 2019; 9(22):6706-6718. PubMed ID: 31588245
[No Abstract] [Full Text] [Related]
3. Recent Advances in Bioorthogonal Click Chemistry for Enhanced PET and SPECT Radiochemistry.
Zhong X; Yan J; Ding X; Su C; Xu Y; Yang M
Bioconjug Chem; 2023 Mar; 34(3):457-476. PubMed ID: 36811499
[TBL] [Abstract][Full Text] [Related]
4. A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry.
Zeglis BM; Sevak KK; Reiner T; Mohindra P; Carlin SD; Zanzonico P; Weissleder R; Lewis JS
J Nucl Med; 2013 Aug; 54(8):1389-96. PubMed ID: 23708196
[TBL] [Abstract][Full Text] [Related]
5. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
[TBL] [Abstract][Full Text] [Related]
6. Pretargeted imaging and radioimmunotherapy of cancer using antibodies and bioorthogonal chemistry.
van de Watering FC; Rijpkema M; Robillard M; Oyen WJ; Boerman OC
Front Med (Lausanne); 2014; 1():44. PubMed ID: 25593917
[TBL] [Abstract][Full Text] [Related]
7. Development of
García-Vázquez R; Jørgensen JT; Bratteby KE; Shalgunov V; Hvass L; Herth MM; Kjær A; Battisti UM
Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215356
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Targeting Nuclear Molecular Imaging Driven by Tetrazine Bioorthogonal Chemistry.
Dong P; Wang X; Zheng J; Zhang X; Li Y; Wu H; Li L
Curr Med Chem; 2020; 27(23):3924-3943. PubMed ID: 31267851
[TBL] [Abstract][Full Text] [Related]
9. Bioorthogonal Click of Colloidal Gold Nanoparticles to Antibodies In vivo.
Poulie CBM; Sporer E; Hvass L; Jørgensen JT; Kempen PJ; Lopes van den Broek SI; Shalgunov V; Kjaer A; Jensen AI; Herth MM
Chemistry; 2022 Nov; 28(61):e202201847. PubMed ID: 35851967
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Evaluation of a Low-Molecular-Weight (11)C-Labeled Tetrazine for Pretargeted PET Imaging Applying Bioorthogonal in Vivo Click Chemistry.
Denk C; Svatunek D; Mairinger S; Stanek J; Filip T; Matscheko D; Kuntner C; Wanek T; Mikula H
Bioconjug Chem; 2016 Jul; 27(7):1707-12. PubMed ID: 27308894
[TBL] [Abstract][Full Text] [Related]
11. Click and Bioorthogonal Chemistry: The Future of Active Targeting of Nanoparticles for Nanomedicines?
Taiariol L; Chaix C; Farre C; Moreau E
Chem Rev; 2022 Jan; 122(1):340-384. PubMed ID: 34705429
[TBL] [Abstract][Full Text] [Related]
12. Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.
Zeglis BM; Brand C; Abdel-Atti D; Carnazza KE; Cook BE; Carlin S; Reiner T; Lewis JS
Mol Pharm; 2015 Oct; 12(10):3575-87. PubMed ID: 26287993
[TBL] [Abstract][Full Text] [Related]
13. Cellular Delivery of Bioorthogonal Pretargeting Therapeutics in PSMA-Positive Prostate Cancer.
Hapuarachchige S; Huang CT; Donnelly MC; Bařinka C; Lupold SE; Pomper MG; Artemov D
Mol Pharm; 2020 Jan; 17(1):98-108. PubMed ID: 31840521
[TBL] [Abstract][Full Text] [Related]
14. Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging.
Mandikian D; Rafidi H; Adhikari P; Venkatraman P; Nazarova L; Fung G; Figueroa I; Ferl GZ; Ulufatu S; Ho J; McCaughey C; Lau J; Yu SF; Prabhu S; Sadowsky J; Boswell CA
MAbs; 2018; 10(8):1269-1280. PubMed ID: 30199303
[TBL] [Abstract][Full Text] [Related]
15. A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer.
Adumeau P; Carnazza KE; Brand C; Carlin SD; Reiner T; Agnew BJ; Lewis JS; Zeglis BM
Theranostics; 2016; 6(12):2267-2277. PubMed ID: 27924162
[TBL] [Abstract][Full Text] [Related]
16. Theranostic Pretargeting Drug Delivery and Imaging Platforms in Cancer Precision Medicine.
Hapuarachchige S; Artemov D
Front Oncol; 2020; 10():1131. PubMed ID: 32793481
[TBL] [Abstract][Full Text] [Related]
17. In Vivo Pretargeting Based on Cysteine-Selective Antibody Modification with IEDDA Bioorthogonal Handles for Click Chemistry.
Ferreira VFC; Oliveira BL; D'Onofrio A; Farinha CM; Gano L; Paulo A; Bernardes GJL; Mendes F
Bioconjug Chem; 2021 Jan; 32(1):121-132. PubMed ID: 33295756
[TBL] [Abstract][Full Text] [Related]
18. The growing impact of bioorthogonal click chemistry on the development of radiopharmaceuticals.
Zeng D; Zeglis BM; Lewis JS; Anderson CJ
J Nucl Med; 2013 Jun; 54(6):829-32. PubMed ID: 23616581
[TBL] [Abstract][Full Text] [Related]
19. Tetrazine bioorthogonal chemistry derived
Zhao G; Li Z; Zhang R; Zhou L; Zhao H; Jiang H
Front Mol Biosci; 2022; 9():1055823. PubMed ID: 36465558
[TBL] [Abstract][Full Text] [Related]
20. Diabody Pretargeting with Click Chemistry In Vivo.
van Duijnhoven SM; Rossin R; van den Bosch SM; Wheatcroft MP; Hudson PJ; Robillard MS
J Nucl Med; 2015 Sep; 56(9):1422-8. PubMed ID: 26159589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
